Seed funding for innovative, cross-disciplinary research advancing understanding and treatment of pediatric IBD and celiac disease, with priority for celiac disease-focused projects.
Funder: Stanford University
Due Dates: September 22, 2026 (Letter of Intent) | February 1, 2027 (Full proposal by invitation)
Funding Amounts: Up to $100,000 per year for 2 years (maximum $200,000 total per project).
Summary: Supports innovative, cross-disciplinary research advancing pediatric IBD and celiac disease, with priority for celiac disease-focused projects.
Key Information: Stanford Center membership required for PI/mentor; multi-PI, cross-disciplinary teams strongly encouraged.
This seed grant program is designed to catalyze innovative, transdisciplinary research that advances understanding, diagnosis, and treatment of pediatric inflammatory bowel disease (IBD) and celiac disease. The initiative encourages collaborations—especially between basic/data scientists and physician scientists—and prioritizes projects focused on celiac disease. The funding targets early-stage, high-risk, high-reward projects not yet ready for large-scale government support, aiming to generate preliminary data for future external grant applications. Eligible research areas include disease mechanisms, novel technologies, clinical research, and computational or systems biology approaches relevant to pediatric IBD and celiac disease.